Don Barkauskas
0000-0002-2339-719X
11 papers found
Refreshing results…
Crizotinib in Combination With Chemotherapy for Pediatric Patients With ALK+ Anaplastic Large-Cell Lymphoma: The Results of Children's Oncology Group Trial ANHL12P1
Germline Genetic Variants and Pediatric Rhabdomyosarcoma Outcomes: A Report from the Children’s Oncology Group
Circulating Tumor DNA Is Prognostic in Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group
Lymph node metastases in paediatric and young adult patients with non-rhabdomyosarcoma soft tissue sarcoma (NRSTS): Findings from Children's Oncology Group (COG) study ARST0332
Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Reply to R. Lakhotia et al
Dose-Adjusted Etoposide, Doxorubicin, and Cyclophosphamide With Vincristine and Prednisone Plus Rituximab Therapy in Children and Adolescents With Primary Mediastinal B-Cell Lymphoma: A Multicenter Phase II Trial
Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium
BRAF V600E/V600K Mutations versus Nonstandard Alterations: Prognostic Implications and Therapeutic Outcomes
Brentuximab vedotin in combination with chemotherapy for pediatric patients with ALK+ ALCL: results of COG trial ANHL12P1
Germline Cancer-Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report from the Children’s Oncology Group
Missing publications? Search for publications with a matching author name.